The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization
暂无分享,去创建一个
László Virág | András Varró | J. Papp | L. Virág | A. Varró | D. A. Lathrop | B. Baláti | János Takács | Julius Gy. Papp | L. Tálosi | N. Iost | J. Takács | Lengyel Csaba | László Tálosi | Beáta Baláti | Norbert Iost | David A. Lathrop | Lengyel Csaba | D. Lathrop
[1] Bramahn . Singh,et al. Antiarrhythmic drugs: a reorientation in light of recent developments in the control of disorders of rhythm. , 1998, The American journal of cardiology.
[2] S Nattel,et al. Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. , 1996, Circulation research.
[3] D A Terrar,et al. Separation of the components of the delayed rectifier potassium current using selective blockers of IKr and IKs in guinea‐pig isolated ventricular myocytes , 1996, Experimental physiology.
[4] S. Priori,et al. Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents. , 1995, Journal of the American College of Cardiology.
[5] E. Carmeliet. Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide. , 1992, The Journal of pharmacology and experimental therapeutics.
[6] C. Antzelevitch,et al. Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial, and endocardial myocytes. A weaker IKs contributes to the longer action potential of the M cell. , 1995, Circulation research.
[7] U. Elkayam,et al. Tolerance: An Historical Overview , 1998 .
[8] Harry J. Witchel,et al. Time course and voltage dependence of expressed HERG current compared with native ”rapid” delayed rectifier K current during the cardiac ventricular action potential , 1998, Pflügers Archiv.
[9] M. Viitasalo,et al. Evaluation of QT interval duration and dispersion and proposed clinical criteria in diagnosis of long QT syndrome in patients with a genetically uniform type of LQT1. , 1998, Journal of the American College of Cardiology.
[10] A. Schömig,et al. Differential Effect of β‐Adrenergic Stimulation on the Frequency‐Dependent Electrophysiologic Actions of the New Class III Antiarrhythmics Dofetilide, Ambasilide, and Chromanol 293. , 1997 .
[11] S. Bryant,et al. Regional differences in the delayed rectifier current (IKr and IKs) contribute to the differences in action potential duration in basal left ventricular myocytes in guinea-pig. , 1998, Cardiovascular research.
[12] C. January,et al. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. , 1998, Biophysical journal.
[13] D. Roden,et al. Block of IKs, the slow component of the delayed rectifier K+ current, by the diuretic agent indapamide in guinea pig myocytes. , 1994, Circulation research.
[14] M. Sanguinetti,et al. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents , 1990, The Journal of general physiology.
[15] L. Opie,et al. Sotalol , 2021, Reactions Weekly.
[16] T. Begenisich,et al. Beta-adrenergic modulation of cardiac ion channels. Differential temperature sensitivity of potassium and calcium currents , 1989, The Journal of general physiology.
[17] C Antzelevitch,et al. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. , 1998, Circulation.
[18] G. Gintant,et al. Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. , 1991, Circulation research.
[19] B. Fermini,et al. IK of rabbit ventricle is composed of two currents: evidence for IKs. , 1996, The American journal of physiology.
[20] D. Noble,et al. Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres , 1969, The Journal of physiology.
[21] M. Fowler. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life? , 1998, European heart journal.
[22] D A Terrar,et al. The deactivation kinetics of the delayed rectifier components IKr and IKs in guinea‐pig isolated ventricular myocytes , 1996, Experimental physiology.
[23] M. Sanguinetti,et al. Role of delayed rectifier potassium channels in cardiac repolarization and arrhythmias , 1997 .
[24] M. Sanguinetti,et al. A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents. , 1998, Molecular pharmacology.
[25] M. Sanguinetti,et al. Fast inactivation causes rectification of the IKr channel , 1996, The Journal of general physiology.
[26] M. Morad,et al. Gender difference in the cycle length-dependent QT and potassium currents in rabbits. , 1998, The Journal of pharmacology and experimental therapeutics.
[27] A. Schömig,et al. Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B. , 1997, Journal of cardiovascular electrophysiology.
[28] M. Sanguinetti,et al. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. , 1993, Circulation research.
[29] D. Snyders,et al. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. , 1990, Circulation.
[30] B. Singh,et al. A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474 , 1970, British journal of pharmacology.
[31] J. Bigger,et al. Electrophysiological and Beta‐Receptor Blocking Effects of MJ 1999 on Dog and Rabbit Cardiac Tissue , 1970, Circulation research.
[32] R. Harvey,et al. Autonomic regulation of a chloride current in heart. , 1989, Science.
[33] A Varró,et al. Delayed rectifier potassium current in undiseased human ventricular myocytes. , 1998, Cardiovascular research.
[34] B. Surawicz. Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations? , 1989, Journal of the American College of Cardiology.
[35] G. Gintant,et al. Two components of delayed rectifier current in canine atrium and ventricle. Does IKs play a role in the reverse rate dependence of class III agents? , 1996, Circulation research.
[36] E. Carmeliet. Mechanisms and control of repolarization. , 1993, European heart journal.
[37] W. Giles,et al. Repolarizing K+ currents in rabbit heart Purkinje cells , 1998, The Journal of physiology.
[38] J. Parratt,et al. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. , 1992, Cardiovascular research.
[39] S. Hohnloser,et al. Drug therapy : Sotalol , 1994 .
[40] S Nattel,et al. Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes. , 1998, Cardiovascular research.
[41] B. Surawicz,et al. Effect of tetraethylammonium chloride on action potential in cardiac Purkinje fibers. , 1981, The American journal of physiology.
[42] S. Nattel,et al. Effects of the chromanol 293 B , a selective blocker of the slow , component of the delayed rectifier K q current , on repolarization in human and guinea pig ventricular myocytes , 1998 .
[43] D. A. Lathrop,et al. Electromechanical characterization of the effects of racemic sotalol and its optical isomers on isolated canine ventricular trabecular muscles and Purkinje strands. , 1985, Canadian journal of physiology and pharmacology.
[44] T. Colatsky,et al. Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes. , 1990, Circulation.
[45] B. Surawicz,et al. Effect of Antiarrhythmic Drugs on the Cycle Length-Dependent Action Potential Duration in Dog Purkinje and Ventricular Muscle Fibers , 1986, Journal of cardiovascular pharmacology.